Online citations, reference lists, and bibliographies.
← Back to Search

Diseases Of Movement And System Degenerations

P. Ince, B. Clark, J. Holton, T. Revesz, S. Wharton
Published 2008 · Computer Science

Cite This
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1002/ana.10850
Disease penetrance in amyotrophic lateral sclerosis associated with mutations in the SOD1 gene
P. Andersen (2004)
10.1001/ARCHNEUR.1996.00550050080027
Delayed-onset cerebellar syndrome.
E. Louis (1996)
10.1046/j.1471-4159.2001.00149.x
Effect of the overexpression of wild‐type or mutant α‐synuclein on cell susceptibility to insult
Moonhee Lee (2001)
10.3171/JNS.1995.83.1.0050
A clinical and neuroradiological study of X-linked hydrocephalus in Japan.
M. Yamasaki (1995)
10.1016/0092-8674(95)90346-1
Amyotrophic lateral sclerosis: Recent insights from genetics and transgenic mice
R. Brown (1995)
10.1212/WNL.38.1.154
Mineralization of the basal ganglia detected by CT in Hallervorden‐Spatz syndrome
M. Tennison (1988)
10.1016/j.expneurol.2003.07.004
SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease
D. Pountney (2003)
10.1523/JNEUROSCI.4461-03.2004
Aberrant Cellular Behavior of Mutant TorsinA Implicates Nuclear Envelope Dysfunction in DYT1 Dystonia
P. González-Alegre (2004)
10.1016/S0092-8674(01)00244-6
Amyotrophic Lateral Sclerosis Unfolding the Toxicity of the Misfolded
J. Julien (2001)
10.1002/ART.1780281214
Basal ganglia calcifications in central nervous system lupus erythematosus.
D. Nordstrom (1985)
10.1016/S0022-510X(02)00006-0
Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies
W. Marui (2002)
10.1002/ana.20484
An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family
M. Funayama (2005)
10.1002/1531-8249(200101)49:1<29::AID-ANA7>3.0.CO;2-B
Quantitative neuropathological changes in presymptomatic Huntington's disease
E. Gómez-Tortosa (2001)
10.1002/1531-8249(20010201)49:2<249::AID-ANA46>3.0.CO;2-3
Absence of echovirus sequences in brain and spinal cord of amyotrophic lateral sclerosis patients
M. P. Walker (2001)
10.1002/ANA.410350202
Amyotrophic lateral sclerosis: Theories and therapies
L. Rowland (1994)
10.1038/72101
Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1
X. Lin (2000)
10.1212/01.WNL.0000158422.41380.82
Cognitive status correlates with neuropathologic stage in Parkinson disease
H. Braak (2005)
10.1212/WNL.48.3.746
Clinical and functional investigation of 10 missense mutations and a novel frameshift insertion mutation of the gene for copper-zinc superoxide dismutase in UK families with amyotrophic lateral sclerosis
R. Orrell (1997)
10.1016/S0304-3940(99)00465-6
The Ile93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease
B. Harhangi (1999)
10.1056/NEJMC055509
LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews.
L. Ozelius (2006)
10.1016/j.neuron.2004.10.023
Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease
C. Paisán-Ruiz (2004)
10.1001/ARCHNEUR.56.1.90
Multiple system atrophy: the putative causative role of environmental toxins.
P. Hanna (1999)
10.1001/ARCHNEUR.56.2.179
Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease.
R. Hauser (1999)
10.1093/BRAIN/AWH276
Mapping of the SCA23 locus involved in autosomal dominant cerebellar ataxia to chromosome region 20p13-12.3.
D. Verbeek (2004)
10.1002/ana.73
DYT13, a novel primary torsion dystonia locus, maps to chromosome 1p36.13–36.32 in an Italian family with cranial‐cervical or upper limb onset
E. M. Valente (2001)
10.1093/BRAIN/118.3.707
Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction.
L. Haverkamp (1995)
10.1111/j.1471-4159.1992.tb10074.x
Detergent‐Insoluble Cortical Lewy Body Fibrils Share Epitopes with Neurofilament and τ
M. Pollanen (1992)
10.1016/S0896-6273(00)80997-6
Aberrant RNA Processing in a Neurodegenerative Disease: the Cause for Absent EAAT2, a Glutamate Transporter, in Amyotrophic Lateral Sclerosis
C. G. Lin (1998)
10.1212/WNL.53.9.2187
Autosomal dominant familial spinal and bulbar muscular atrophy with gynecomastia
K. Ikezoe (1999)
10.1016/S0304-3940(96)13316-4
Apolipoprotein E e4 allele frequency in patients with multiple system atrophy
N. Cairns (1997)
10.1086/429256
Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations.
J. Kachergus (2005)
10.1212/WNL.26.10.947
Neuropathologic changes in ataxia‐telangiectasia
G. A. de León (1976)
10.1016/S0092-8674(00)80623-6
Reversal of Neuropathology and Motor Dysfunction in a Conditional Model of Huntington's Disease
A. Yamamoto (2000)
10.1177/096368970000900205
Improving the Survival of Grafted Dopaminergic Neurons: A Review over Current Approaches
P. Brundin (2000)
10.1002/MDS.870040106
Posttraumatic movement disorders: A review
W. Koller (1989)
10.1136/BMJ.304.6825.471
Motor neurone disease: a hospice perspective.
T. O'Brien (1992)
10.1007/s100480100111
Novel mutation in the TOR1A (DYT1) gene in atypical, early onset dystonia and polymorphisms in dystonia and early onset parkinsonism
Joanne Leung (2001)
10.1007/BF00315688
Sudden death and paroxysmal autonomic dysfunction in stiff-man syndrome
H. Mitsumoto (2004)
10.1007/BF00294656
Occurrence of 15-nm-wide straight tubules in neocortical neurons in progressive supranuclear palsy
H. Takahashi (2004)
10.1038/362059a0
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
D. R. Rosen (1993)
10.1001/ARCHPSYC.1988.01800250087012
Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs.
L. Farde (1988)
10.1212/WNL.40.1.172
How frequently does classic amyotrophic lateral sclerosis develop in survivors of poliomyelitis?
C. Armon (1990)
10.1016/S0165-0173(02)00234-5
Manganese action in brain function
A. Takeda (2003)
10.1212/WNL.42.3.652
Relationship of birth weight to the phenotypic expression of Gilles de la Tourette's syndrome in monozygotic twins
T. Hyde (1992)
10.1016/0022-510X(73)90114-7
Hallervorden-Spatz disease and infantile neuroaxonal dystrophy. Ultrastructural observations, anatomical pathology and nosology.
R. Defendini (1973)
10.1016/0022-510X(89)90082-8
The nucleus pontis centralis caudalis in Huntington's disease
A. Koeppen (1989)
10.1212/WNL.41.11.1847
Stroke‐like syndrome, mineralizing microangiopathy, and neuroaxonal dystrophy following intrathecal methotrexate therapy
K. Phanthumchinda (1991)
Peripheral motor-sensory neuropathy in membranous lipodystrophy (Nasu's disease): a case report.
S. Iannaccone (1992)
10.1007/s004150170245
Clinical and genetic analysis of a four-generation family with a distinct autosomal dominant cerebellar ataxia
H. Schelhaas (2001)
10.1136/BMJ.321.7252.21
Cross sectional prevalence survey of idiopathic Parkinson's disease and parkinsonism in London
A. Schrag (2000)
10.1046/J.1468-1331.1999.660639.X
Manganese‐containing superoxide dismutase signal sequence polymorphism associated with sporadic motor neuron disease
G. F. Landeghem (1999)
10.1523/JNEUROSCI.2978-04.2004
Recovery from Polyglutamine-Induced Neurodegeneration in Conditional SCA1 Transgenic Mice
T. Zu (2004)
10.1007/BF00376710
Calcification of the basal ganglia following carbon monoxide poisoning
F. Illum (2004)
Workshop reportCriteria for Diagnosis of Familial Amyotrophic Lateral Sclerosis
Michael Swash (1992)
Paraneoplastic motor neuron disease.
M. Rosenfeld (1991)
10.1002/ANA.410430612
Hereditary form of parkinsonism—dementia
M. Muenter (1998)
10.1016/j.neuron.2004.11.005
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
A. Zimprich (2004)
10.1001/ARCHNEUR.60.8.1045
The hereditary spastic paraplegias: nine genes and counting.
J. Fink (2003)
10.1136/JNNP.71.2.265
Motor neuron disease after electric injury.
H. Jafari (2001)
10.1002/ana.10757
Hereditary spastic paraparesis: Disrupted intracellular transport associated with spastin mutation
C. Mcdermott (2003)
10.1146/ANNUREV.BIOCHEM.74.082803.133400
The biochemistry of Parkinson's disease.
M. Cookson (2005)
10.1038/NG0494-409
Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm
H. Telenius (1994)
10.1016/0304-3940(94)90010-8
Argyrophilic thread-like structure in corticobasal degeneration and supranuclear palsy
K. Ikeda (1994)
10.1002/ANA.410120403
Acute neurological dysfunction associated with destructive lesions of the basal ganglia in children
F. Goutières (1982)
10.1159/000107312
Presenile dementia with motor neuron disease.
Y. Mitsuyama (1993)
10.1016/S0304-3940(00)01440-3
Characterisation of isolated α-synuclein filaments from substantia nigra of Parkinson's disease brain
R. Crowther (2000)
10.1111/j.1365-2990.1989.tb01146.x
CORTICAL AND SUBCORTICAL ARGYROPHILIC GRAINS CHARACTERIZE A DISEASE ASSOCIATED WITH ADULT ONSET DEMENTIA
H. Braak (1989)
10.1002/ANA.410380321
A novel mitochondrial ATPase 6 point mutation in familial bilateral striatal necrosis
D. Thyagarajan (1995)
10.1038/NG1293-386
Linkage mapping of dopa–responsive dystonia (DRD) to chromosome 14q
T. Nygaard (1993)
10.1126/science.271.5256.1731
Mutations in the Gene Encoding Cystatin B in Progressive Myoclonus Epilepsy (EPM1)
L. Pennacchio (1996)
10.1016/S0896-6273(02)00872-3
Polyglutamine Pathogenesis Emergence of Unifying Mechanisms for Huntington's Disease and Related Disorders
C. Ross (2002)
10.1212/WNL.49.2.568
Spinobulbar muscular atrophy can mimic ALS: The importance of genetic testing in male patients with atypical ALS
J. Parboosingh (1997)
10.1016/0022-510X(91)90112-K
Skein-like inclusions in the anterior horn cells in motor neuron disease
H. Mizusawa (1991)
10.1016/S0733-8619(05)70129-8
Selected legal issues in movement disorders.
L. Nora (1999)
10.1212/WNL.59.8.1183
A novel locus for inherited myoclonus-dystonia on 18p11
D. Grimes (2002)
10.1007/s11910-996-0011-1
Hereditary spastic paraplegia
J. Fink (2002)
10.1056/NEJM199205283262204
Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis.
J. Rothstein (1992)
10.1212/WNL.54.1.20
Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS
M. Berger (2000)
10.1002/ANA.410420314
Congenital axonal neuropathy caused by deletions in the spinal muscular atrophy region
R. Korinthenberg (1997)
10.1111/J.1471-4159.1993.TB07478.X
Superoxide Dismutase Activity, Oxidative Damage, and Mitochondrial Energy Metabolism in Familial and Sporadic Amyotrophic Lateral Sclerosis
A. Bowling (1993)
10.1016/S0140-6736(04)17103-1
α-synuclein locus duplication as a cause of familial Parkinson's disease
M. Chartier‐Harlin (2004)
10.1002/ANA.410040309
Sparing of the onufrowicz nucleus in sacral anterior horn lesions
M. Iwata (1978)
Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.
P. Anglade (1997)
10.1111/j.1399-0004.2005.00445.x
Refinement of the chromosome 16 locus for benign familial infantile convulsions
P. Callenbach (2005)
10.1212/WNL.48.2.384
Survival of patients with pathologically proven multiple system atrophy
Y. Ben-Shlomo (1997)
10.1136/jnnp.51.4.540
The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease.
K. Jellinger (1988)
10.1136/jmg.28.5.345
Infantile spinal muscular atrophy (SMA) and multiple congenital bone fractures in sibs: a lethal new syndrome.
Z. Borochowitz (1991)
10.1038/88821
A conserved sorting-associated protein is mutant in chorea-acanthocytosis
L. Rampoldi (2001)
10.1212/WNL.56.2.234
Clinical features and genetic analysis of a new form of spinocerebellar ataxia
D. Devos (2001)
10.1523/JNEUROSCI.21-20-08053.2001
Induction of α-Synuclein Aggregation by Intracellular Nitrative Insult
E. Paxinou (2001)
10.1093/BRAIN/AWH651
SCA28, a novel form of autosomal dominant cerebellar ataxia on chromosome 18p11.22-q11.2.
C. Cagnoli (2006)
10.1073/PNAS.95.11.6469
α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies
M. Spillantini (1998)
10.1002/1531-8249(200004)47:4<521::AID-ANA18>3.0.CO;2-B
Synphilin‐1 is present in Lewy bodies in Parkinson's disease
K. Wakabayashi (2000)
10.1093/BRAIN/113.2.433
Acute infantile spinal muscular atrophy. Muscle apoptosis as a proposed pathogenetic mechanism.
A. Fidziańska (1990)
10.1038/NG1093-168
De novo expansion of a (CAG)n repeat in sporadic Huntington's disease
R. Myers (1993)
10.1016/S0140-6736(89)92366-0
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
A. Schapira (1989)
10.1046/j.1440-1789.2001.00390.x
Distribution and dynamic process of neuronal cytoplasmic inclusion (NCI) in MSA: Correlation of the density of NCI and the degree of involvement of the pontine nuclei
T. Yokoyama (2001)
10.1002/ANA.410110403
Neuroaxonal dystrophy in young adults: A clinicopathological study of two unrelated cases
K. Williamson (1982)
10.1093/BRAIN/104.2.351
Laryngeal abductor paralysis in multiple system atrophy. A report on three necropsied cases, with observations on the laryngeal muscles and the nuclei ambigui.
R. Bannister (1981)
10.1074/JBC.M212436200
Effects of Oxidative and Nitrative Challenges on α-Synuclein Fibrillogenesis Involve Distinct Mechanisms of Protein Modifications*
E. Norris (2003)
10.1002/ana.20021
Involvement of medullary serotonergic groups in multiple system atrophy
E. Benarroch (2004)
10.1093/BRAIN/114.5.2283
Ageing and Parkinson's disease: substantia nigra regional selectivity.
J. Fearnley (1991)
10.1016/J.PHRS.2005.01.001
Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery.
C. Zuccato (2005)
10.1093/BRAIN/AWH381
Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients.
H. Adachi (2005)
10.1038/ng0894-513
Identification and characterization of the gene causing type 1 spinocerebellar ataxia
S. Banfi (1994)
10.1007/s004150050425
The stiff man and stiff man plus syndromes
P. Brown (1999)
10.1212/WNL.31.6.774
Pallidonigral pigmentation and spheroid formation with multiple striatal lacunar infarcts
R. Kim (1981)
10.1136/jnnp.47.4.399
Alexander's disease with Rosenthal fibre formation in an adult.
T. Walls (1984)
10.1016/0022-510X(86)90097-3
Gilles de la Tourette's syndrome: A postmortem neuropathological and immunohistochemical study
S. Haber (1986)
10.1212/WNL.43.2.418
Motor neuron diseases and amyotrophic lateral Sclerosis
K. Sanders (1993)
10.1212/WNL.57.1.96
A novel autosomal dominant spinocerebellar ataxia (SCA16) linked to chromosome 8q22.1-24.1
Y. Miyoshi (2001)
10.1073/PNAS.96.9.5173
Association of a missense change in the D2 dopamine receptor with myoclonus dystonia.
C. Klein (1999)
10.1212/WNL.44.1.159
A case of Down's syndrome with diffuse Lewy body disease and Alzheimer's disease
S. Bodhireddy (1994)
10.1007/PL00007400
NACP/α-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson’s disease brains
K. Wakabayashi (2000)
10.1038/81593
Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice
I. Dragatsis (2000)
10.1016/j.expneurol.2004.07.016
Tau phosphorylation increases in symptomatic mice overexpressing A30P α-synuclein
M. Frasier (2005)
10.3109/13550289809113478
Molecular aspects of poliovirus biology with a special focus on the interactions with nerve cells.
Bruno Blondel (1998)
10.1007/BF00686786
Diffuse Lewy body disease
D. Dickson (2004)
Cortical and subcortical pathology in Parkinson's disease: relationship to parkinsonian dementia.
J. Xuereb (1990)
10.1161/01.STR.25.4.787
Cardiovascular Autonomic Reflexes in Brain Infarction
J. Korpelainen (1994)
10.1007/BF00690978
Lewy bodies in cerebral cortex. Report of three cases
K. Kosaka (2004)
10.1093/BRAIN/AWF109
Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy.
H. Morris (2002)
10.1093/BRAIN/114.4.1559
Early onset cerebellar ataxia with retained tendon reflexes. Clinical, electrophysiological and MRI observations in comparison with Friedreich's ataxia.
T. Klockgether (1991)
10.1126/SCIENCE.2530630
The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase.
K. Wilkinson (1989)
10.1146/ANNUREV.NE.09.030186.002041
Parallel organization of functionally segregated circuits linking basal ganglia and cortex.
G. E. Alexander (1986)
10.1126/science.271.5254.1423
Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion
V. Campuzano (1996)
10.1016/0303-8467(80)90016-5
An adult with hallervorden-spatz disease: Clinical and pathological study
S. Kalyanasundaram (1980)
10.1097/00002093-198900000-00002
Lewy Bodies in Alzheimer Disease‐One or Two Diseases?
C. Bergeron (1989)
10.1212/WNL.35.6.921
Cyanide‐induced parkinsonism
R. Uitti (1985)
10.1212/WNL.42.12.2300
Strong correlation between the number of CAG repeats in androgen receptor genes and the clinical onset of features of spinal and bulbar muscular atrophy
S. Igarashi (1992)
10.1038/77153
Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts
J. Paloneva (2000)
10.1016/S0002-9440(10)65578-2
Cell-specific survival motor neuron gene expression during human development of the central nervous system: implications for the pathogenesis of spinal muscular atrophy.
E. Tizzano (1998)
10.1016/S0022-510X(00)00422-6
Cytoskeletal abnormalities in amyotrophic lateral sclerosis: beneficial or detrimental effects?
J. Julien (2000)
10.1086/302744
Localization of the gene for a novel autosomal recessive neurodegenerative Huntington-like disorder to 4p15.3.
M. Kambouris (2000)
10.1016/S0079-6123(08)62678-3
Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions.
G. E. Alexander (1990)
10.1038/26652
The ubiquitin pathway in Parkinson's disease
E. Leroy (1998)
10.14670/HH-15.1285
Considerations on the thalamostriatal system with some functional implications.
J. Giménez-Amaya (2000)
10.1002/ANA.410440216
Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy
M. Li (1998)
10.1002/ana.100
Familial amyotrophic lateral sclerosis and parkinsonism‐dementia complex of the Kii peninsula of Japan: Clinical and neuropathological study and tau analysis
S. Kuzuhara (2001)
10.1046/j.1440-1789.2000.00297.x
Nasu–Hakola disease: A review of its leukoencephalopathic and membranolipodystrophic features
J. Tanaka (2000)
10.1093/OXFORDJOURNALS.QJMED.A068320
Wilson's disease presenting with features of hepatic dysfunction: a clinical analysis of eighty-seven patients.
J. Walshe (1989)
10.1007/BF03159935
Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway.
K. Jellinger (1991)
10.1002/ANA.410390119
SOD1 mutation is assosiated with accumulation of neurofilaments in amyotrophic lateral scelaries
G. Rouleau (1996)
10.1093/JNEN/64.4.280
Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights.
M. Mancuso (2005)
10.1523/JNEUROSCI.20-17-06365.2000
Subcellular Localization of Wild-Type and Parkinson's Disease-Associated Mutant α-Synuclein in Human and Transgenic Mouse Brain
P. Kahle (2000)
10.1212/WNL.51.6.1546
Frontotemporal lobar degeneration
D. Neary (1998)
10.1038/3311
Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease
K. Conway (1998)
Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.
M. Baba (1998)
10.1086/302495
Autosomal dominant cerebellar ataxia type III: linkage in a large British family to a 7.6-cM region on chromosome 15q14-21.3.
P. Worth (1999)
10.1523/JNEUROSCI.20-16-06021.2000
Neuropathology in Mice Expressing Human α-Synuclein
H. van der Putten (2000)
10.1212/01.WNL.0000145601.88274.88
Genetic heterogeneity in familial idiopathic basal ganglia calcification (Fahr disease)
J. R. Oliveira (2004)
10.1016/S0022-510X(99)00191-4
Free radicals, oxidative stress and the origin of Parkinson’s disease
J. Bennett (1999)
10.1017/S0317167100031280
Familial amyotrophic lateral sclerosis, 1850-1989: a statistical analysis of the world literature.
M. J. Strong (1991)
10.1016/J.DNAREP.2004.04.009
Ataxia-telangiectasia-like disorder (ATLD)-its clinical presentation and molecular basis.
A. Taylor (2004)
10.1001/ARCHNEUR.59.1.102
Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response.
H. Apaydin (2002)
10.1001/ARCHNEUR.58.3.365
Glutamate transporters in neurologic disease.
N. Maragakis (2001)
10.1093/BRAIN/AWH584
α-Synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease
G. Halliday (2005)
10.1038/ng1609
Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia
G. Skibinski (2005)
10.1093/JNEN/61.11.935
Office of Rare Diseases Neuropathologic Criteria for Corticobasal Degeneration
D. Dickson (2002)
10.1111/j.1440-1789.2003.00543.x
Pathological heterogeneity in progressive supranuclear palsy and corticobasal degeneration
K. Wakabayashi (2004)
10.1016/0022-510X(93)90018-T
Widespread multiple system degeneration in a patient with familial amyotrophic lateral sclerosis
H. Takahashi (1993)
10.1002/ana.10340
An R5L τ mutation in a subject with a progressive supranuclear palsy phenotype
P. Poorkaj (2002)
10.1001/ARCHNEUR.1974.00490310072012
Hallervorden-Spatz syndrome.
E. Dooling (1974)
10.1097/00005792-197005000-00003
THE OLIVOPONTOCEREBELLAR ATROPHIES: A REVIEW
B. Konigsmark (1970)
A contemporary case of encephalitis lethargica.
M. Kiley (2001)
Classification of dystonia.
S. Fahn (1998)
10.1007/s007020200027
Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease
K. Jellinger (2002)
10.1056/NEJM198604103141505
A long-term follow-up study of patients with post-poliomyelitis neuromuscular symptoms.
M. Dalakas (1986)
10.1212/WNL.55.12.1918
Multiple system atrophy/progressive supranuclear palsy: α-Synuclein, synphilin, tau, and APOE
H. Morris (2000)
10.1002/jnr.10567
TorsinA in PC12 cells: Localization in the endoplasmic reticulum and response to stress
J. Hewett (2003)
10.1016/S0022-510X(98)00137-3
Kinesin and cytoplasmic dynein in spinal spheroids with motor neuron disease
I. Toyoshima (1998)
10.1016/S0022-510X(98)00169-5
Familial neuronal intranuclear inclusion disease with ubiquitin positive inclusions
T. Kimber (1998)
10.1002/ANA.410270403
Striatal and nigral neuron subpopulations in rigid Huntington's disease: Implications for the functional anatomy of chorea and rigidity‐akinesia
R. Albin (1990)
10.1093/BRAIN/113.6.1823
Striatonigral degeneration. A clinicopathological study.
J. Fearnley (1990)
10.1111/j.1365-2990.1994.tb00951.x
Hirano bodies and related neuronal inclusions
A. Hirano (1994)
10.1093/BRAIN/110.5.1131
Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia).
W. Gibb (1987)
10.1093/BRAIN/110.4.993
Adult onset Hallervorden-Spatz disease with neurofibrillary pathology. A discrete clinicopathological entity.
D. Eidelberg (1987)
10.1055/S-2008-1059553
Diagnosis of infantile neuro-axonal dystrophy by conjunctival biopsy.
I. Ferrer (1983)
10.1096/fj.04-3258fje
BimEL up‐regulation potentiates AIF translocation and cell death in response to MPTP
A. Liou (2005)
10.1002/MDS.870070409
Corticobasal degeneration: Decreased and asymmetrical glucose consumption as studied with PET
J. Blin (1992)
10.1002/MDS.870090303
The neuropathological features of neuroacanthocytosis
J. Rinne (1994)
10.1111/J.1749-6632.1995.TB27527.X
Post‐Polio Syndrome 12 Years Later
M. Dalakas (1995)
10.1016/0022-510X(90)90225-C
The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's disease
B. Bloem (1990)
10.1007/978-3-7091-6641-3_11
The neuropathology of progressive supranuclear palsy.
P. Lantos (1994)
10.1016/S0140-6736(05)17828-3
Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease
W. Nichols (2005)
10.1006/exnr.2000.7607
Further Evidence for Mitochondrial Dysfunction in Progressive Supranuclear Palsy
D. S. Albers (2001)
10.1111/j.1750-3639.1999.tb00549.x
Tau‐positive dial Inclusions in Progressive Supranuclear Palsy, Corticobasal Degeneration and Pick's Disease
T. Komori (1999)
10.1016/S0022-510X(00)00350-6
Progressive muscular atrophy variant of familial amyotrophic lateral sclerosis (PMA/ALS)
L. Červen̆áková (2000)
10.1093/JNEN/64.6.545
Neuronal intranuclear inclusion disease without polyglutamine inclusions in a child.
K. McFadden (2005)
10.1016/S0896-6273(03)00533-6
RNA-Mediated Neurodegeneration Caused by the Fragile X Premutation rCGG Repeats in Drosophila
P. Jin (2003)
10.1016/S0006-8993(01)02986-9
Neuronal nuclear alterations in dentatorubral-pallidoluysian atrophy: ultrastructural and morphometric studies of the cerebellar granule cells
Hitoshi Takahashi (2001)
10.1002/ana.10179
Role of parkin mutations in 111 community‐based patients with early‐onset parkinsonism
M. Kann (2002)
10.1002/ana.10344
A new locus for spinocerebellar ataxia (SCA21) maps to chromosome 7p21.3‐p15.1
I. Vuillaume (2002)
10.1002/MDS.870050209
Diffuse lewy body disease with dementia and oculomotor dysfunction
A. Lewis (1990)
10.1002/ANA.410360412
Trinucleotide repeat length and rate of progression of Huntington's disease
Sergei N. Illarioshkin (1994)
10.1093/BRAIN/117.4.747
Frontal lobe atrophy in motor neuron diseases.
J. Kiernan (1994)
10.1016/0887-8994(91)90007-8
Terminal axon pathology in infantile neuroaxonal dystrophy.
S. Kimura (1991)
10.1212/WNL.53.1.44
Phenotypic analysis of autosomal dominant hereditary spastic paraplegia linked to chromosome 8q
P. Hedera (1999)
10.1212/WNL.41.2_Part_1.174
Dopa‐responsive dystonia
T. Nygaard (1991)
[FAMILIAL CEREBELLAR ATROPHY WITH ASSOCIATION OF NIGERIAN AND SPINAL LESIONS].
J. Sigwald (1964)
10.1038/88842
Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration
B. Oosthuyse (2001)
10.1046/j.1471-4159.2002.01190.x
TorsinA and heat shock proteins act as molecular chaperones: suppression of α‐synuclein aggregation
P. McLean (2002)
10.1002/mds.20084
Development of Parkinson's disease in patients with blepharospasm
F. Micheli (2004)
10.1002/mds.20537
Grading of neuropathology in multiple system atrophy: Proposal for a novel scale
K. Jellinger (2005)
10.1002/MDS.870130205
Glial pathology but absence of apoptotic nigral neurons in long‐standing Parkinson's disease
R. Banati (1998)
10.1002/ana.20529
Amphiphysin autoimmunity: Paraneoplastic accompaniments
S. Pittock (2005)
10.1002/ana.10846
Comparison of kindreds with parkinsonism and α‐synuclein genomic multiplications
M. Farrer (2004)
10.1055/S-2001-13121
Familial (idiopathic) paroxysmal dyskinesias: an update.
K. Bhatia (2001)
10.1038/nm1314
Dopamine covalently modifies and functionally inactivates parkin
Matthew J LaVoie (2005)
10.1016/S0140-6736(04)17104-3
Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease
P. Ibáñez (2004)
10.1093/JNEN/59.7.585
α‐Synuclein Inclusions in Amygdala in the Brains of Patients with the Parkinsonism‐Dementia Complex of Guam
M. Yamazaki (2000)
10.1002/ANA.410420507
Differential distribution of the normal and mutated forms of huntingtin in the human brain
I. Gourfinkel-An (1997)
10.1093/HMG/4.7.1213
A gene for a severe lethal form of X-linked arthrogryposis (X-linked infantile spinal muscular atrophy) maps to human chromosome Xp11.3-q11.2.
H. Kobayashi (1995)
10.1002/ANA.410380518
Neurological sequelae of cyanide intoxication — the patterns of clinical, magnetic resonance imaging, and positron emission tomography findings
F. Rosenow (1995)
10.1002/MDS.870080221
Familial idiopathic strio‐pallido‐dentate calcifications with late onset extrapyramidal syndrome
P. Martinelli (1993)
10.1111/j.1365-2990.1986.tb00136.x
IDIOPATHIC PARKINSON'S DISEASE AND THE LEWY BODY DISORDERS
W. Gibb (1986)
10.1093/HMG/9.18.2683
Expression of mutant α-synuclein causes increased susceptibility to dopamine toxicity
S. Tabrizi (2000)
10.1007/s004019900177
A double-labeling immunohistochemical study of tau exon 10 in Alzheimer’s disease, progressive supranuclear palsy and Pick’s disease
K. Ishizawa (2000)
10.1038/37144
Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy
H. Iwahashi (1997)
10.1002/ana.10795
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Juan J. Zarranz (2004)
10.1093/BRAIN/116.1.281
Pathological overlap in cases of parkinsonism associated with neurofibrillary tangles. A study of recent cases of postencephalitic parkinsonism and comparison with progressive supranuclear palsy and Guamanian parkinsonism-dementia complex.
J. Geddes (1993)
10.1111/j.1365-2990.1993.tb00443.x
Parvalbumin and calbindin D‐28k in the human motor system and in motor neuron disease
P. Ince (1993)
10.1111/j.1365-2990.1992.tb00830.x
Comparison of modified Bielschowsky silver impregnation and anti‐ubiquitin immunostaining of cortical and nigral Lewy bodies
S. Love (1992)
10.1007/BF00863768
Disease-specific patterns of neuronal loss in the spinal ventral horn in amyotrophic lateral sclerosis, multiple system atrophy and X-linked recessive bulbospinal neuronopathy, with special reference to the loss of small neurons in the intermediate zone
S. Terao (2004)
10.1093/BRAIN/AWH008
Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity.
R. Dale (2004)
10.1126/SCIENCE.1086071
Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice
A. M. Clement (2003)
10.1038/ng1123
Mutant dynactin in motor neuron disease
I. Puls (2003)
10.1016/S0960-9822(01)00517-6
Macromolecular complexes: SMN — the master assembler
M. Terns (2001)
10.1016/S0959-437X(00)00199-4
Molecular basis of inherited spastic paraplegias.
G. Casari (2001)
10.1016/0022-510X(95)00050-C
The validation of El Escorial criteria for the diagnosis of amyotrophic lateral sclerosis: A clinicopathological study
K. Chaudhuri (1995)
10.1016/S1090-3798(99)80015-4
Prenatal onset spinal muscular atrophy.
M. Macleod (1999)
10.1159/000007915
Hypertrophy of the Inferior Olivary Nucleus in Patients with Progressive Supranuclear Palsy
T. Hanihara (1998)
10.1016/S0891-0618(02)00099-6
The nucleus raphe interpositus in spinocerebellar ataxia type 3 (Machado–Joseph disease)
U. Rüb (2003)
10.1073/PNAS.0402959101
The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization
R. Canet-Avilés (2004)
10.1093/HMG/8.2.157
Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis.
A. Al-Chalabi (1999)
10.1016/S0304-3940(98)00407-8
α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy
K. Wakabayashi (1998)
10.1093/BRAIN/AWL005
Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa.
P. Ibáñez (2006)
10.1002/ana.1124
A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion
R. Margolis (2001)
10.1002/ana.10782
DJ‐1 colocalizes with tau inclusions: A link between parkinsonism and dementia
P. Rizzu (2004)
10.1111/j.1365-2990.1993.tb00459.x
Neuronophagia in the motor cortex in amyotrophic lateral sclerosis
D. Troost (1993)
10.1016/S0387-7604(00)00138-8
RETRACTED: Approach to ex vivo gene therapy in the treatment of Parkinson's disease
A. Ishida (2000)
10.1016/S0896-6273(00)80943-5
Intranuclear Inclusions of Expanded Polyglutamine Protein in Spinocerebellar Ataxia Type 3
H. Paulson (1997)
10.1016/0167-4943(87)90021-5
Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology.
A. Brun (1987)
Cytoskeletal changes and ubiquitin expression in dystrophic axons of Seitelberger's disease.
G. Moretto (1993)
10.1007/BF00687047
Pathology of skeletal muscle and intramuscular nerves in infantile neuroaxonal dystrophy
T. Miike (2004)
10.1212/WNL.54.7.1510
Age-related cognitive decline in hereditary spastic paraparesis linked to chromosome 2p
P. Byrne (2000)
10.1007/BF00311398
Sporadic amyotrophic lateral sclerosis with extensive neurological involvement
S. Sasaki (2004)
10.1097/00019052-200108000-00012
Autonomic dysfunction in movement disorders
K. Chaudhuri (2001)
10.1007/BF00687231
Neurofibrillary pathology in progressive supranuclear palsy
N. Ghatak (2004)
10.1002/ANA.410420117
Sporadic focal dystonia in Northwest Germany: Molecular basis on chromosome 18p
B. Leube (1997)
10.1007/BF00294466
Motor neuron disease with neurofibrillary tangles in a non-Guamanian patient
D. Hilton (2004)
10.1002/MDS.870120203
Multiple system atrophy: A review of 203 pathologically proven cases
G. Wenning (1997)
10.1002/mds.10579
Correlation of dopamine transporter imaging with parkinsonian motor handicap: How close is it?
W. Pirker (2003)
10.1093/HMG/3.4.649
Identification of a novel S0D1 mutation in an apparently sporadic amyotrophic lateral sclerosis patient and the detection of lle113Thr in three others
C. Jones (1994)
10.1002/ANA.410220411
Tau antisera recognize neurofibrillary tangles in a range of neurodegenerative disorders
C. Joachim (1987)
10.1007/BF00688179
Pathology of the dentate nucleus in progressive supranuclear palsy: a histological, immunohistochemical and ultrastructural study
H. Mizusawa (2004)
10.1002/ANA.410200403
Locus ceruleus lesions and eosinophilic inclusions in MPTP‐treated monkeys
L. Forno (1986)
10.1111/j.1750-3639.1998.tb00159.x
Corticobasal Ganglionic Degeneration and Progressive Supranuclear Palsy Presenting with Cognitive Decline
C. Bergeron (1998)
10.1074/JBC.M000206200
Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies.
J. M. Souza (2000)
10.1126/SCIENCE.276.5321.2045
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
M. Polymeropoulos (1997)
10.1016/S0896-6273(00)80886-7
Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System
A. Abeliovich (2000)
10.1016/S1474-4422(02)00161-8
Progressive supranuclear palsy: where are we now?
D. Burn (2002)
10.1212/WNL.30.9.1005
Intracranial calcification in hyperparathyroidism associated with gait apraxia and parkinsonism
D. Margolin (1980)
10.1016/0022-510X(85)90063-2
Brainstem findings in Huntington's disease: Possible mechanisms for slow vertical saccades
R. Leigh (1985)
10.1212/WNL.42.11.2144
Rapid postanoxic calcification of the basai ganglia
G. Midroni (1992)
10.1007/BF00662643
Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles
W. Paulus (2004)
10.1016/S0140-6736(05)17829-5
A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease
A. D. Fonzo (2005)
10.1136/jmg.36.1.1
Spinal muscular atrophy: untangling the knot?
I. Biros (1999)
10.1001/ARCHNEUR.57.2.205
Striatal dopamine transporter binding assessed by [I-123]IPT and single photon emission computed tomography in patients with early Parkinson's disease: implications for a preclinical diagnosis.
J. Schwarz (2000)
10.1001/ARCHNEUR.61.12.1956
Phenotypic and molecular analyses of X-linked dystonia-parkinsonism ("lubag") in women.
V. Evidente (2004)
10.1056/NEJMOA033277
Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews.
J. Aharon-Peretz (2004)
10.1038/ng1001-166
A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2
S. Hadano (2001)
10.1007/s00439-002-0828-x
Genetic testing and risk assessment for spinal muscular atrophy (SMA)
S. Ogino (2002)
10.1038/NG0193-14
Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein
J. Chelly (1993)
10.1001/ARCHNEUR.1991.00530240091029
Hallervorden-Spatz syndrome and brain iron metabolism.
K. Swaiman (1991)
10.1007/BF00839209
Neurological disorders in 166 patients with basal ganglia calcification: a statistical evaluation
Hans Förstl (2004)
10.1001/ARCHNEUR.1989.00520430068020
Ataxia, chorea, seizures, and dementia. Pathologic features of a newly defined familial disorder.
T. Farmer (1989)
10.1016/S1474-4422(02)00137-0
Classification and genetics of dystonia
P. M. Aguiar (2002)
10.1080/14734220410019048
Spinocerebellar ataxia type 20
E. Storey (2008)
10.1097/00019052-199708000-00011
The clinical and pathologic hallmarks of progressive supranuclear palsy.
I. Litvan (1997)
Cytoskeletal pathology in motor neuron diseases.
P. Leigh (1991)
10.1212/WNL.51.3.890
Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q
H. Mori (1998)
10.1016/0022-510X(76)90114-3
Morphometric studies of the neuropathological changes in choreatic diseases
H. Lange (1976)
10.1016/S0304-3940(98)00890-8
Argyrophilic glial inclusions in the midbrain of patients with Parkinson's disease and diffuse Lewy body disease are immunopositive for NACP/α-synuclein
T. Arai (1999)
10.1002/1531-8249(199902)45:2<200::AID-ANA10>3.0.CO;2-U
Friedreich's ataxia: Point mutations and clinical presentation of compound heterozygotes
M. Cossée (1999)
10.1002/ana.20449
Genetic linkage of autosomal dominant progressive supranuclear palsy to 1q31.1
R. Ros (2005)
10.1016/S0304-3940(01)02254-6
A novel presenilin mutation (M233V) causing very early onset Alzheimer's disease with Lewy bodies
H. Houlden (2001)
10.1126/SCIENCE.1077209
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
V. Bonifati (2002)
10.1016/0304-3940(96)12314-4
Ultrastructural study of synapses in the anterior horn neurons of patients with amyotrophic lateral sclerosis
S. Sasaki (1996)
10.1002/MDS.870070410
Diffuse lewy body disease presenting with supranuclear gaze palsy, parkinsonism, and dementia: A case report
V. M. D. de Bruin (1992)
10.1126/SCIENCE.280.5369.1610
Axonal swellings and degeneration in mice lacking the major proteolipid of myelin.
I. Griffiths (1998)
10.1073/pnas.172514599
Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP
W. Dauer (2002)
10.1073/PNAS.96.11.6307
A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy.
C. L. Lorson (1999)
10.1093/HMG/8.4.711
Association of an extended haplotype in the tau gene with progressive supranuclear palsy.
M. Baker (1999)
10.1111/j.1749-6632.2000.tb06180.x
Oxidative Stress, Mitochondrial Respiration, and Parkinson's Disease
G. Cohen (2000)
10.1093/BRAIN/110.1.19
Encephalitis lethargica. A report of four recent cases.
R. Howard (1987)
10.1007/BF00342514
Prevalences of CT-detected calcification in the basal ganglia in idiophathic hypoparathyroidism and pseudohypoparathyroidism
F. Illum (2004)
10.1212/WNL.48.6.1671
Lymphoproliferative disorders and motor neuron disease
P. Gordon (1997)
10.1016/0960-8966(92)90020-7
Criteria for Diagnosis of Familial Amyotrophic Lateral Sclerosis
M. Swash (1992)
10.1007/BF00309344
Parkinsonism in motor neuron disease: case report and literature review
T. H. Williams (2004)
10.1016/S0962-8924(00)01852-3
Aggresomes, inclusion bodies and protein aggregation.
R. Kopito (2000)
10.1007/s004010050918
Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy
K. Wakabayashi (1998)
10.1038/15472
Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia
J. Hazan (1999)
10.1016/1353-8020(95)00011-T
The pathophysiology of chorea/ballism and Parkinsonism.
R. Albin (1995)
10.1136/jnnp.53.3.271-b
Unilateral paresis of the abdominal wall.
L. Benaim (1990)
10.1016/S0022-510X(99)00184-7
What is primary lateral sclerosis?
M. Swash (1999)
10.1016/S0006-8993(00)02702-5
TorsinA accumulation in Lewy bodies in sporadic Parkinson’s disease
P. Shashidharan (2000)
10.1007/s004010051052
A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy
M. Delisle (1999)
10.1515/CCLM.2001.047
Parkinsons Disease and other α-Synucleinopathies
M. Goedert (2001)
10.1002/1531-8249(199905)45:5<577::AID-ANA5>3.0.CO;2-O
The role of inheritance in sporadic Parkinson's disease: Evidence from a longitudinal study of dopaminergic function in twins
P. Piccini (1999)
10.1001/ARCHNEUR.1997.00550200007003
What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study.
I. Litvan (1997)
10.1007/BF00868999
Survival in multiple system atrophy: a study of prognostic factors in 59 cases
D. Testa (2004)
10.1002/ANA.410380405
Paroxysmal dyskinesias: Clinical features and classification
M. Demirkiran (1995)
10.1007/BF00688247
Chromatolytic neurons in Werdnig-Hoffmann disease contain phosphorylated neurofilaments
C. Lippa (2004)
10.1007/BF00688682
Histological and ultrastructural features of dystrophic isocortical axons in infantile neuroaxonal dystrophy (Seitelberger's disease)
G. A. León (2004)
10.1136/PGMJ.69.807.68
Idiopathic calcification of the basal ganglia.
H. Chiu (1993)
10.1002/MDS.870100307
CYP2D6‐debrisoquine hydroxylase gene polymorphism in multiple system atrophy
V. Planté-Bordeneuve (1995)
10.1001/ARCHINTE.1991.00400080101019
Comparison of the lipid profiles of Cubans and other Hispanics with non-Hispanics.
M. Kato (1991)
10.1046/j.1440-1789.2003.00524.x
Neuronal intranuclear hyaline inclusion disease
J. Takahashi-Fujigasaki (2003)
10.1038/NG0395-267
A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans
K. Yoshida (1995)
10.1016/0022-510X(94)00263-N
Onuf's nucleus is frequently involved in motor neuron disease/amyotrophic lateral sclerosis
M. Bergmann (1995)
10.1136/jnnp.55.12.1106
Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950.
A. Chancellor (1992)
10.1212/WNL.56.12.1702
Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype
H. Houlden (2001)
Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies.
M. L. Schmidt (1991)
10.1006/exnr.2002.8050
Altered Proteasomal Function in Sporadic Parkinson's Disease
K. McNaught (2003)
10.1038/35040009
Apoptosis in neurodegenerative disorders
M. Mattson (2000)
10.1007/s004010050446
Progressive supranuclear palsy: a clinicopathological study of 21 cases
M. Verny (1996)
10.1097/00005072-199007000-00002
Atrophy of the Hypothalamic Lateral Tuberal Nucleus in Huntington's Disease
H. Kremer (1990)
10.1016/S0896-6273(03)00568-3
Parkinson's Disease Mechanisms and Models
W. Dauer (2003)
10.1212/WNL.53.5.1032
Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia
Y. Furukawa (1999)
10.1002/MDS.870030209
Meige syndrome: Neuropathology of a case
J. Kulisevsky (1988)
10.1007/BF00313987
Bilateral ballism: A rare syndrome
M. C. Hoogstraten (2004)
10.1007/s00401-005-1061-1
Extensive cortico-subcortical lesions in Wilson’s disease: clinico-pathological study of two cases
J. Mikol (2005)
10.1002/ana.10512
Proteolytic stress: A unifying concept for the etiopathogenesis of Parkinson's disease
K. S. P. McNaught (2003)
10.1002/ana.20731
Lrrk2 and Lewy body disease
O. Ross (2006)
10.1093/BRAIN/124.8.1666
Progressive supranuclear palsy as a disease phenotype caused by the S305S tau gene mutation.
Z. Wszolek (2001)
Neuronal intranuclear hyaline inclusion disease: report of a case and review of the literature.
N. Funata (1990)
10.1046/j.1365-2443.2001.00447.x
AAA+ superfamily ATPases: common structure–diverse function
T. Ogura (2001)
10.1046/J.1365-2990.1998.00108.X
Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology.
P. Ince (1998)
10.1002/mds.10523
Unclassifiable parkinsonism in two European tertiary referral centres for movement disorders
R. Katzenschlager (2003)
10.1007/BF00690971
Ultrastructure of the Bunina bodies in anterior horn cells of amyotrophic lateral sclerosis
M. Tomonaga (2004)
10.1385/JMN:23:1-2:023
Interactions among α-synuclein, dopamine, and biomembranes
Jean-Christophe Rochet (2007)
10.1038/ng721
Wildtype Kras2 can inhibit lung carcinogenesis in mice
Z. Zhang (2001)
10.1212/WNL.52.9.1899
Molecular genetic analysis of the APEX nuclease gene in amyotrophic lateral sclerosis
C. Hayward (1999)
10.1007/s004010100451
Immunocytochemical localization of synphilin-1, an α-synuclein-associated protein, in neurodegenerative disorders
K. Wakabayashi (2002)
10.1086/302558
Identification of a locus on chromosome 14q for idiopathic basal ganglia calcification (Fahr disease).
D. Geschwind (1999)
10.1016/0016-5085(78)90476-6
A familial neuronal disease presenting as intestinal pseudoobstruction
M. Schuffler (1978)
10.1038/ng1196-269
Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2
S. Pulst (1996)
10.1177/147130120500400110
The ‘Talking About Memory Coffee Group’: A new model of support for people with early-stage dementia and their families
R. Pratt (2005)
10.1016/0022-510X(89)90219-0
Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome)
M. Papp (1989)
10.1007/s100480100118
Rescue of the Friedreich's ataxia knockout mouse by human YAC transgenesis
M. Pook (2001)
10.1016/S0140-6736(99)04137-9
Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study
A. Schrag (1999)
10.1258/JRSM.95.4.201
Meige's syndrome in dementia with Lewy bodies.
N. Tabet (2002)
10.1002/ana.67
Clinical and pathological features of a parkinsonian syndrome in a family with an Ala53Thr α‐synuclein mutation
P. Spira (2001)
10.1002/ANA.410150403
Neuronal intranuclear inclusion disease in identical twins
M. Haltia (1984)
10.1093/BRAIN/104.1.79
Distribution of cerebral lesions in acquired hepatocerebral degeneration.
M. Finlayson (1981)
10.1111/j.1750-3639.2000.tb00269.x
Lewy Bodies in Alzheimer's Disease: A Neuropathological Review of 145 Cases Using α‐Synuclein Immunohistochemistry
R. Hamilton (2000)
10.1007/s004010000208
Familial frontotemporal dementia with ubiquitin inclusion bodies and without motor neuron disease
E. Kövari (2000)
10.1001/ARCHNEUR.57.8.1214
The brain lesion responsible for parkinsonism after carbon monoxide poisoning.
Y. Sohn (2000)
10.1038/352077A0
Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
A. L. Spada (1991)
10.1002/mds.10078
In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain
Zaodung Ling (2002)
10.1007/BF00294619
Lewy bodies in the lower sacral parasympathetic neurons of a patient with Parkinson's disease
K. Oyanagi (2004)
10.1002/ANA.410220503
Abnormal glutamate metabolism in amyotrophic lateral sclerosis
A. Plaitakis (1987)
10.1093/BRAIN/AWH054
The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease.
R. Bandopadhyay (2004)
10.1007/s00401-004-0825-3
Neonatal spinal muscular atrophy with multiple contractures, bone fractures, respiratory insufficiency and 5q13 deletion
M. A. García-Cabezas (2004)
10.1007/s00401-004-0949-5
Ferritinopathy: diagnosis by muscle or nerve biopsy, with a note on other nuclear inclusion body diseases
J. M. Schröder (2004)
10.1212/01.WNL.0000147299.80872.D1
Autosomal dominant congenital non-progressive ataxia overlaps with the SCA15 locus
T. Dudding (2004)
10.1212/WNL.43.4.791
Kennedy's disease
A. Amato (1993)
10.1212/WNL.54.4.1003
Potential role of LIF as a modifier gene in the pathogenesis of amyotrophic lateral sclerosis
R. Giess (2000)
10.1080/13554790590963004
Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia
K. Josephs (2005)
10.1016/j.nbd.2005.03.021
Synphilin-1 and parkin show overlapping expression patterns in human brain and form aggresomes in response to proteasomal inhibition
R. Bandopadhyay (2005)
10.1136/jmg.33.6.458
Human alpha-N-acetylgalactosaminidase (alpha-NAGA) deficiency: new mutations and the paradox between genotype and phenotype.
J. Keulemans (1996)
10.1007/BF00293318
Immunocytochemical and ultrastructural studies of the motor cortex in amyotrophic lateral sclerosis
S. Sasaki (2004)
10.1016/S0896-6273(03)00258-7
Serine 776 of Ataxin-1 Is Critical for Polyglutamine-Induced Disease in SCA1 Transgenic Mice
E. S. Emamian (2003)
10.1093/BRAIN/AWH139
Dominantly inherited ataxia and dysphonia with dentate calcification: spinocerebellar ataxia type 20.
M. Knight (2004)
10.1016/S0022-510X(00)00446-9
Asymptomatic CTG expansion at the SCA8 locus is associated with cerebellar atrophy on MRI
Y. Ikeda (2000)
10.1007/s00401-005-1011-y
Cerebellopontine calcification: a new entity of idiopathic intracranial calcification?
Y. Saito (2005)
10.1001/ARCHNEUR.62.3.353
Molecular pathogenesis of Parkinson disease.
Jason L. Eriksen (2005)
10.1093/BRAIN/121.4.601
Autosomal dominant hereditary spastic paraparesis with cognitive loss linked to chromosome 2p.
S. Webb (1998)
10.1016/S1474-4422(03)00501-5
The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?
D. Monte (2003)
10.1016/0006-8993(88)91111-0
An electron microscopic study of MPTP-induced inclusion bodies in an old monkey
L. Forno (1988)
10.1016/0092-8674(95)90460-3
Identification and characterization of a spinal muscular atrophy-determining gene
S. Lefebvre (1995)
10.1038/NG1293-344
The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene
R. Tanzi (1993)
Adult onset Hallervorden-Spatz syndrome or Seitelberger's disease with late onset: variants of the same entity? A clinico-pathological study.
S. Gaytan-Garcia (1990)
10.1001/ARCHNEUR.1984.04050220085023
Lipofuscin in amyotrophic lateral sclerosis.
G. McHolm (1984)
10.1001/ARCHNEUR.1964.00460160003001
PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.
J. Steele (1964)
10.1212/wnl.50.3.583
Progressive proximal spinal and bulbar muscular atrophy of late onset
W. Kennedy (1998)
10.1093/BRAIN/34.4.295
PROGRESSIVE LENTICULAR DEGENERATION: A FAMILIAL NERVOUS DISEASE ASSOCIATED WITH CIRRHOSIS OF THE LIVER
S. A. Wilson (1912)
10.1097/00001756-200001170-00041
MPTP induces alpha‐synuclein aggregation in the substantia nigra of baboons
N. Kowall (2000)
10.1056/NEJM199403033300901
A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group.
G. Bensimon (1994)
10.1212/WNL.44.6.1015
Progressive supranuclear palsy
M. Gearing (1994)
10.1016/S0022-510X(96)00240-7
The relationship of spinal muscular atrophy to motor neuron disease: Investigation of SMN and NAIP gene deletions in sporadic and familial ALS
R. Orrell (1997)
10.1201/b12948-7
Epidemiology of Parkinson's disease.
C. Tanner (1996)
10.1007/s004010050956
Large motor neuron involvement in Stiff-man syndrome: a qualitative and quantitative study
K. Ishizawa (1999)
10.1097/00005072-197907000-00001
PATHOLOGY OF SHY‐DRAGER SYNDROME*
J. H. Sung (1979)
10.1086/380647
The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval.
A. Zimprich (2004)
10.1016/S0733-8619(18)30187-7
Trauma and movement disorders.
C. Götz (1992)
10.1212/WNL.35.2.227
Late‐onset Hallervorden‐Spatz disease presenting as familial parkinsonism
J. Jankovic (1985)
10.1523/JNEUROSCI.19-07-02522.1999
Nuclear and Neuropil Aggregates in Huntington’s Disease: Relationship to Neuropathology
C. Gutekunst (1999)
Death from hyponatraemia-induced cerebral oedema associated with MDMA ("Ecstasy") use.
A. O'Connor (1999)
10.1016/S0092-8674(00)81203-9
Spastic Paraplegia and OXPHOS Impairment Caused by Mutations in Paraplegin, a Nuclear-Encoded Mitochondrial Metalloprotease
G. Casari (1998)
10.1001/ARCHNEUR.58.7.1076
Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy.
M. Warmuth-Metz (2001)
10.1016/J.NBD.2005.08.002
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
A. Gerhard (2006)
10.1001/ARCHINTE.1994.00420140086011
The causes of chronic orthostatic hypotension.
C. Tung (1985)
A hyperthermic reaction to 'ecstasy'.
T. Walsh (1994)
10.1002/path.1283
NEDD8 protein is involved in ubiquitinated inclusion bodies
Afroz Dil Kuazi (2003)
10.1093/BRAIN/118.5.1095
Familial progressive supranuclear palsy. Description of a pedigree and review of the literature.
J. D. de Yébenes (1995)
10.1046/j.0305-1846.2001.00342.x
α‐Synuclein pathology is highly dependent on the case selection
L. Parkkinen (2001)
10.1002/MDS.870060202
Head trauma as a risk factor for Parkinson's disease
M. Stern (1991)
10.1002/MDS.870060211
Gastrointestinal symptoms in Parkinson's disease
L. Edwards (1991)
10.1001/ARCHNEUR.1968.00470310034003
Corticodentatonigral degeneration with neuronal achromasia.
J. Rebeiz (1968)
10.1093/BRAIN/99.1.27
Progressive encephalomyelitis with rigidity.
A. Whiteley (1976)
10.1093/HMG/10.17.1847
α-synuclein gene haplotypes are associated with Parkinson’s disease
M. Farrer (2001)
10.1126/SCIENCE.1067389
Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease
P. Auluck (2001)
10.1016/S0022-510X(02)00314-3
Pro-inflammatory cytokines and motor neuron dysfunction: Is there a connection in post-polio syndrome?
M. Dalakas (2002)
10.1073/PNAS.0304375101
Mislocalization to the nuclear envelope: an effect of the dystonia-causing torsinA mutation.
Rose E Goodchild (2004)
10.1042/BST0290661
ATM (ataxia telangiectasia mutated): expanding roles in the DNA damage response and cellular homeostasis.
Y. Shiloh (2001)
10.1016/0304-3940(90)90419-A
Ubiquitinated filamentous inclusions in spinal cord of patients with motor neuron disease
A. Migheli (1990)
10.1002/mds.20162
In vivo imaging of microglial activation with [11C](R)‐PK11195 PET in corticobasal degeneration
A. Gerhard (2004)
10.1126/SCIENCE.8209258
Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.
M. Gurney (1994)
10.1002/ANA.410340219
Dopa resistance in multiple‐system atrophy: Loss of postsynaptic D2 receptors
A. Churchyard (1993)
10.1111/j.1365-2990.1995.tb01056.x
Neurodegeneration in the limbic and paralimbic system in progressive supranuclear palsy
Y. Higuchi (1995)
10.1212/WNL.31.6.714
Dystrophic axons and spinal cord demyelination in cystic fibrosis
S. Cavalier (1981)
10.1016/0022-510X(91)90284-E
Multisystem involvement of the central nervous system in Strümpell's disease A neurophysiological and neuropsychological study
G. Tedeschi (1991)
10.1136/jnnp.42.9.773
Spinal internuncial neurones in progressive encephalomyelitis with rigidity.
D. Howell (1979)
10.1097/00005072-199710000-00002
Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease
B. Hyman (1997)
10.1016/0022-510X(70)90001-8
Chronic proximal spinal muscular atrophy.
T. Namba (1970)
10.1080/14734220410019029
Spinocerebellar ataxia type 15
R. J. Gardner (2008)
10.1212/WNL.55.12.1794
Phenotype of AD-HSP due to mutations in the SPAST gene
P. McMonagle (2000)
10.1212/WNL.40.6.960
Paraneoplastic motor neuron disease and renal cell carcinoma
B. K. Evans (1990)
10.1001/ARCHNEUR.56.1.33
Diagnostic criteria for Parkinson disease.
D. Gelb (1999)
10.1126/SCIENCE.307.5711.836
SUMO Wrestles Its Way to Prominence in the Cell
J. Marx (2005)
10.1007/s00401-005-1013-9
α-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy
M. Sone (2005)
10.1007/s00415-005-0811-2
Different clinical and evolutional patterns in late idiopathic and vascular parkinsonism
L. Rampello (2005)
10.1002/ANA.410430119
Cytochrome c Oxidase subunit I microdeletion in a patient with motor neuron disease
G. Comi (1998)
10.1001/ARCHPSYC.1989.01810120068011
Wilson's disease. Psychiatric symptoms in 195 cases.
T. Dening (1989)
10.1016/0304-3940(89)90003-7
Inclusion bodies in motor cortex and brainstem of patients with motor neurone disease are detected by immunocytochemical localisation of ubiquitin
J. Lowe (1989)
10.1038/42166
α-Synuclein in Lewy bodies
M. Spillantini (1997)
10.1093/HMG/8.11.2047
A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease?
R. Koide (1999)
10.1212/01.wnl.0000187889.17253.b1
Diagnosis and management of dementia with Lewy bodies
I. McKeith (2005)
10.1002/ana.20247
Homozygous PINK1 C‐terminus mutation causing early‐onset parkinsonism
C. Rohé (2004)
10.1093/HMG/DDH138
The structure of the tau haplotype in controls and in progressive supranuclear palsy.
A. Pittman (2004)
10.1002/ana.10358
ε‐sarcoglycan mutations found in combination with other dystonia gene mutations
C. Klein (2002)
10.1002/(SICI)1096-8628(20000515)92:2<117::AID-AJMG7>3.0.CO;2-C
Brown-Vialetto-Van Laere syndrome in a large inbred Lebanese family: confirmation of autosomal recessive inheritance?
A. Mégarbané (2000)
10.1126/SCIENCE.1096284
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
E. M. Valente (2004)
10.1055/S-2007-1001190
Primäre Degeneration des Thalamus mit Demenz - Zwei Beobachtungen mit familiärem Hintergrund
G. Goecke-Hoyer (1990)
10.1007/BF03160568
Positron emission tomography studies of sleep and sleep disorders
P. Maquet (2009)
10.1016/S0161-813X(02)00092-X
Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype.
M. Thiruchelvam (2002)
10.1097/00019052-200008000-00006
Recent advances in amyotrophic lateral sclerosis
A. Al-Chalabi (2000)
Stiff-man syndrome with spinal cord lesion.
N. Nakamura (1986)
10.1016/0022-510X(90)90236-G
Senile dementia of Lewy body type: A clinically and neuropathologically distinct form of Lewy body dementia in the elderly
R. Perry (1990)
10.1007/s00415-003-0236-8
The clinical expression of primary dystonia
Alberto Albanese (2003)
10.1212/01.WNL.0000125015.06989.DB
Autosomal dominant parkinsonism associated with variable synuclein and tau pathology
Z. Wszolek (2004)
10.1212/WNL.59.4.627
CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects
K. Buerger (2002)
10.1212/01.WNL.0000072325.27824.A5
Tau exon 10 +16 mutation FTDP-17 presenting clinically as sporadic young onset PSP
H. Morris (2003)
10.1016/S1474-4422(04)00827-0
Lewy-body formation is an aggresome-related process: a hypothesis
C. Olanow (2004)
10.1038/70493
Expansion of a novel CAG trinucleotide repeat in the 5′ region of PPP2R2B is associated with SCA12
S. Holmes (1999)
10.1093/BRAIN/123.12.2423
Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence.
J. M. Graham (2000)
10.1001/ARCHNEUR.1981.00510030080012
Progressive pontobulbar palsy with deafness: clinical and pathological study of two cases.
J. M. Brucher (1981)
10.1002/1531-8257(200007)15:4<699::AID-MDS1015>3.0.CO;2-L
Stridor and death in multiple system atrophy
M. Silber (2000)
10.1002/MDS.870130403
Case ascertainment uncertainties in prevalence surveys of Parkinson's disease
D. Anderson (1998)
10.1038/ng0194-9
Unstable expansion of CAG repeat in hereditary dentatorubral–pallidoluysian atrophy (DRPLA)
R. Koide (1994)
10.1007/BF00687373
Lewy body-like hyaline inclusions in sporadic motor neuron disease are ubiquitinated
T. Kato (2004)



This paper is referenced by
10.1016/j.ejrad.2011.12.012
"Hot cross bun" sign in multiple system atrophy with predominant cerebellar ataxia: a comparison between proton density-weighted imaging and T2-weighted imaging.
Seiko Kasahara (2012)
10.1371/journal.pone.0009002
A Neurotoxic Phosphoform of Elk-1 Associates with Inclusions from Multiple Neurodegenerative Diseases
A. Sharma (2010)
10.1111/nan.12148
Loss of nuclear TDP‐43 in amyotrophic lateral sclerosis (ALS) causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neurones
J. R. Highley (2014)
Neuropathological findings and staging in dementia
H. Brunnström (2011)
10.1053/J.SEMDP.2010.05.004
Nontumor lesions of spinal cord and spine.
M. Tatke (2010)
10.7748/nop.28.2.13.s16
Parkinson's disease.
Dominic R Errington (2016)
The use of next generation sequencing technologies to dissect the aetiologies of Parkinson's disease and dystonia
U. Sheerin (2014)
10.1016/j.neuroscience.2010.01.017
Pigmented creatine deposits in Amyotrophic Lateral Sclerosis central nervous system tissues identified by synchrotron Fourier Transform Infrared microspectroscopy and X-ray fluorescence spectromicroscopy
M. Kastyak (2010)
10.1007/s00401-008-0406-y
A critical reappraisal of current staging of Lewy-related pathology in human brain
K. Jellinger (2008)
10.1007/s00415-009-5243-y
Formation and development of Lewy pathology: a critical update
K. Jellinger (2009)
10.1016/j.neurobiolaging.2011.11.001
Tau acts as an independent genetic risk factor in pathologically proven PD
G. Charlesworth (2012)
Unravelling the tangled web of atypical parkinsonism
H. Ling (2014)
10.1111/psyg.12122
Presenile onset of spinocerebellar ataxia type 1 presenting with conspicuous psychiatric symptoms and widespread anti‐expanded polyglutamine antibody‐ and fused in sarcoma antibody‐immunopositive pathology
Y. Iwasaki (2015)
Non-motor and neuropsychiatric features of Parkinson's disease
D. A. Gallagher (2013)
10.1007/s00401-011-0913-0
Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology
P. Ince (2011)
10.1177/1040638712442352
Vascular mineralization in the brain of horses
J. Martínez (2012)
10.1016/j.neurobiolaging.2011.10.032
Screening for VPS35 mutations in Parkinson's disease
U. Sheerin (2012)
10.5692/clinicalneurol.cn-001096
[Retinal vasculopathy with cerebral leukoencephalopathy carrying TREX1 mutation diagnosed by the intracranial calcification: a case report].
R. Komaki (2018)
10.1177/1040638717721579
Axonal spheroids in ovine neuroaxonal dystrophy are immunopositive to kinesin and dynein
J. Finnie (2017)
Cerebellar Expression of Copper Chaperone for Superoxide, Cytosolic Cu/Zn-Superoxide Dismutase, 4-Hydroxy-2-Nonenal, Acrolein and Heat Shock Protein 32 in Patients with Menkes Kinky Hair Disease: Immunohistochemical Study
A. Yokoyama (2014)
10.1016/j.jcpa.2011.09.006
Neuroaxonal dystrophy in Australian Merino lambs.
A. Kessell (2012)
10.1016/j.jcpa.2017.02.006
Neuroaxonal Dystrophy in a Flock of Pied Imperial Pigeons (Ducula bicolor).
M. Barrows (2017)
10.1099/vir.0.062083-0
Complex proteinopathy with accumulations of prion protein, hyperphosphorylated tau, α-synuclein and ubiquitin in experimental bovine spongiform encephalopathy of monkeys.
P. Piccardo (2014)
10.1111/neup.12240
Oligogenic inheritance of optineurin (OPTN) and C9ORF72 mutations in ALS highlights localisation of OPTN in the TDP‐43‐negative inclusions of C9ORF72‐ALS
Joanna J. Bury (2016)
10.1007/978-1-4939-7290-6_9
HIV-Related Peripheral Nervous System Illness
Jocelyn M. Jiao (2017)
10.1111/j.1750-3639.2012.00611.x
Etiologies of Parkinsonism in a Century‐Long Autopsy‐Based Cohort
J. Horváth (2013)
10.2478/s13380-012-0013-1
The role of α-synuclein in neurodegeneration — An update
K. Jellinger (2012)
10.1016/j.neurobiolaging.2012.04.006
The MAPT p.A152T variant is a risk factor associated with tauopathies with atypical clinical and neuropathological features
E. Kara (2012)
10.1111/j.1440-1789.2011.01288.x
Benign hereditary chorea 2: Pathological findings in an autopsy case
Y. Yoshida (2012)
10.1186/s40478-019-0717-3
Hippocampal CA2 Lewy pathology is associated with cholinergic degeneration in Parkinson’s disease with cognitive decline
A. K. L. Liu (2019)
Semantic Scholar Logo Some data provided by SemanticScholar